Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · Real-Time Price · USD
2.940
+0.300 (11.36%)
Jun 16, 2025, 4:00 PM - Market closed
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $12.82 million as of June 17, 2025. Its market cap has increased by 169.72% in one year.
Market Cap
12.82M
Enterprise Value
8.62M
1-Year Change
169.72%
Ranking
Category
Stock Price
$2.94
Market Cap Chart
Since the IPO on December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from $32.74M to $12.82M, a decrease of -60.83%. That is a compound annual growth rate of -31.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 11.79M | 219.86% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -45.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |